Bosentan in Pulmonary Hypertension associated with Fibrotic Idiopathic Interstitial Pneumonia:A Randomized, Double-Blind, Placebo-controlled Study
Phase of Trial: Phase III
Latest Information Update: 22 Oct 2013
Price : $35 *
At a glance
- Drugs Bosentan (Primary)
- Indications Pulmonary hypertension
- Focus Therapeutic Use
- 22 Oct 2013 New trial record
- 11 Sep 2013 Primary endpoint 'Clinical-response-rate' has not been met.
- 11 Sep 2013 Results presented at the 23rd Annual Congress of the European Respiratory Society.